stoxline Quote Chart Rank Option Currency Glossary
  
BlackRock Health Sciences Trust (BME)
39.21  -0.12 (-0.31%)    06-03 16:00
Open: 39.15
High: 39.85
Volume: 70,130
  
Pre. Close: 39.33
Low: 39.15
Market Cap: 507(M)
Technical analysis
2026-06-03 4:42:40 PM
Short term     
Mid term     
Targets 6-month :  46.17 1-year :  47.28
Resists First :  39.53 Second :  40.47
Pivot price 39.42
Supports First :  37.99 Second :  31.61
MAs MA(5) :  39.77 MA(20) :  39.27
MA(100) :  39.77 MA(250) :  37.42
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  52.3 D(3) :  69.3
RSI RSI(14): 48.3
52-week High :  41.9 Low :  32.77
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BME ] has closed above bottom band by 38.4%. Bollinger Bands are 0.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 39.76 - 40 40 - 40.18
Low: 38.57 - 38.89 38.89 - 39.13
Close: 38.79 - 39.26 39.26 - 39.61
Company Description

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Headline News

Tue, 02 Jun 2026
Discipline and Rules-Based Execution in BME Response - Stock Traders Daily

Fri, 29 May 2026
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions - Quantisnow

Mon, 25 May 2026
BlackRock Health Sciences Trust - INDmoney

Fri, 22 May 2026
BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway - Seeking Alpha

Sun, 29 Mar 2026
BME: Removal Of Option Writing Can Improve NAV Growth (Rating Upgrade) - Seeking Alpha

Fri, 20 Mar 2026
5 ‘Healthy’ Dividends Paying Up to 14.1% - Contrarian Outlook

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Financial Services
Industry:
Asset Management
Shares Out 13 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 20.5 (%)
Shares Short 56 (K)
Shares Short P.Month 82 (K)
Stock Financials
EPS 5.92
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 43.97
Profit Margin 994.9 %
Operating Margin 20.2 %
Return on Assets (ttm) 0.1 %
Return on Equity (ttm) 13.8 %
Qtrly Rev. Growth 7.5 %
Gross Profit (p.s.) 0.59
Sales Per Share 0.59
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 55 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio 6.62
PEG Ratio 0
Price to Book value 0.89
Price to Sales 65.45
Price to Cash Flow 9.28
Stock Dividends
Dividend 0.25
Forward Dividend 0
Dividend Yield 0.6%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android